Scholarlink

<p>This study evaluated the safety of <i>Lactococcus lactis</i> subsp. <i>lactis</i> CAB701 for probiotic application using integrated phenotypic and genotypic approaches. Phenotypic evaluations demonstrated the absence of hemolytic activity, bile salt deconjugation, mucin degradation, gelatin liquefaction, D-lactic acid production, and β-glucuronidase activity. Minimum inhibitory concentration testing showed that the strain was susceptible to clinically relevant antibiotics, with all values below the European Food Safety Authority cut-off thresholds. <i>In vitro</i> assays further confirmed that <i>L. lactis</i> subsp. <i>lactis</i> CAB701 did not exert cytotoxic effects on Caco-2 intestinal epithelial cells and did not produce biogenic amines. Whole-genome sequencing revealed no acquired antimicrobial resistance genes, virulence determinants, or genes associated with toxic metabolite production. Collectively, these phenotypic and genomic findings indicate that <i>L. lactis</i> subsp. <i>lactis</i> CAB701 fulfills established safety criteria and supports its suitability for use as a probiotic strain.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Comprehensive genotypic and phenotypic safety assessment of Lactococcus lactis subsp. lactis CAB701 as a probiotic candidate

  • 期刊论文

  • 发表日期：

    2026年5月26日

查看全文
  • Huijin Jeong,
  • Young-Seo Park,
  • Jong Hun Lee

摘要

This study evaluated the safety of Lactococcus lactis subsp. lactis CAB701 for probiotic application using integrated phenotypic and genotypic approaches. Phenotypic evaluations demonstrated the absence of hemolytic activity, bile salt deconjugation, mucin degradation, gelatin liquefaction, D-lactic acid production, and β-glucuronidase activity. Minimum inhibitory concentration testing showed that the strain was susceptible to clinically relevant antibiotics, with all values below the European Food Safety Authority cut-off thresholds. In vitro assays further confirmed that L. lactis subsp. lactis CAB701 did not exert cytotoxic effects on Caco-2 intestinal epithelial cells and did not produce biogenic amines. Whole-genome sequencing revealed no acquired antimicrobial resistance genes, virulence determinants, or genes associated with toxic metabolite production. Collectively, these phenotypic and genomic findings indicate that L. lactis subsp. lactis CAB701 fulfills established safety criteria and supports its suitability for use as a probiotic strain.